Synergy Pharmaceuticals, Inc.
(NASDAQ : SGYP)

( )
SGYP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
1.53%16.612.0%$163.34m
PRGOPerrigo Co. Plc
-1.50%44.526.8%$125.64m
SAGESAGE Therapeutics, Inc.
2.77%135.609.5%$118.42m
JAZZJazz Pharmaceuticals Plc
0.13%128.172.2%$94.28m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.05%128.616.3%$74.28m
PTLAPortola Pharmaceuticals, Inc.
2.37%25.537.7%$61.81m
ICPTIntercept Pharmaceuticals, Inc.
-1.13%110.8018.6%$54.35m
MNKMallinckrodt Plc
0.30%20.0121.1%$45.03m
CTLTCatalent Inc
1.67%34.642.4%$41.21m
AXSMAxsome Therapeutics, Inc.
1.51%8.062.7%$40.50m
UTHRUnited Therapeutics Corporation
-1.16%113.6214.4%$39.59m
ICLRICON Plc
-1.85%133.804.1%$39.58m
ENDPEndo International Plc
0.31%9.668.9%$36.88m
HZNPHorizon Pharma plc
-1.04%21.927.4%$30.81m
MDCOMedicines Company
-0.20%19.8021.8%$29.37m

Company Profile

Synergy Pharmaceuticals, Inc. engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai on November 15, 2005 and is headquartered in New York, NY.